Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 1
2010 2
2013 3
2015 1
2016 1
2017 2
2018 3
2019 3
2020 1
2021 5
2022 4
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
The patient journey of fibromyalgia in Latin America.
Otón T, Messina OD, Fernández Ávila DG, Robles San Román M, Mata D, Arguissain C, Galindo Guzmán JM, Pérez M, Carmona L; Grupo Fibrojourney Latam. Otón T, et al. Reumatol Clin (Engl Ed). 2024 Jan;20(1):32-42. doi: 10.1016/j.reumae.2023.12.002. Epub 2024 Jan 4. Reumatol Clin (Engl Ed). 2024. PMID: 38182526 Free article.
Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
Beaudart C, Sharma M, Clark P, Fujiwara S, Adachi JD, Messina OD, Morin SN, Kohlmeier LA, Sangan CB, Nogues X, Cruz-Priego GA, Cavallo A, Cooper F, Grier J, Leckie C, Montiel-Ojeda D, Papaioannou A, Raskin N, Yurquina L, Wall M, Bruyère O, Boonen A, Dennison E, Harvey NC, Kanis JA, Kaux JF, Lewiecki EM, Lopez-Borbon O, Paskins Z, Reginster JY, Silverman S, Hiligsmann M. Beaudart C, et al. Among authors: messina od. Osteoporos Int. 2024 Mar;35(3):451-468. doi: 10.1007/s00198-023-06955-9. Epub 2023 Nov 13. Osteoporos Int. 2024. PMID: 37955683 Free PMC article.
First Ecuadorian statement consensus for the evaluation and treatment of osteoporosis.
Rios C, Maldonado G, Vargas S, González J, Vera C, Zuñiga A, Martínez J, Castillo M, Jervis R, Ventura R, Guevara S, Torres G, Uguña F, Messina OD, Neyro JL, Fernández D, Guerrero R, Moreno M. Rios C, et al. Arch Osteoporos. 2023 Jun 15;18(1):81. doi: 10.1007/s11657-023-01263-5. Arch Osteoporos. 2023. PMID: 37316765
Chronic arthritides and bone structure: focus on rheumatoid arthritis-an update.
Messina OD, Vidal M, Adami G, Vidal LF, Clark P, Torres JAM, Lems W, Zerbini C, Arguissain C, Reginster JY, Lane NE. Messina OD, et al. Aging Clin Exp Res. 2023 Jul;35(7):1405-1416. doi: 10.1007/s40520-023-02432-9. Epub 2023 May 24. Aging Clin Exp Res. 2023. PMID: 37222927 Free article. Review.
Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update : This manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF).
Messina OD, Vidal M, Torres JAM, Vidal LF, Arguissain C, Pereira RM, Clark P, Cerdas Perez S, Campusano C, Lazaretti-Castro M, Zerbini C, Scali JJ, Mendez Sanchez L, Peralta-Pedrero ML, Cavallo A, Valdivia Ibarra FJ, Hernandez Pérez T. Messina OD, et al. Aging Clin Exp Res. 2022 Nov;34(11):2591-2602. doi: 10.1007/s40520-022-02261-2. Epub 2022 Nov 9. Aging Clin Exp Res. 2022. PMID: 36348222 Review.
Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3).
Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching DWT, Messina OD, Burmester GR, Genovese M, Bartok B, Pechonkina A, Kondo A, Yin Z, Gong Q, Tasset C, Takeuchi T. Atsumi T, et al. Mod Rheumatol. 2023 Jul 4;33(4):657-667. doi: 10.1093/mr/roac083. Mod Rheumatol. 2023. PMID: 35921235 Clinical Trial.
Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment.
Geusens P, Bevers MS, van Rietbergen B, Messina OD, Lespessailles E, Oliveri B, Chapurlat R, Engelke K, Chines A, Huang S, Saag KG, van den Bergh JP. Geusens P, et al. Among authors: messina od. J Bone Miner Res. 2022 Jun;37(6):1136-1146. doi: 10.1002/jbmr.4551. Epub 2022 Apr 19. J Bone Miner Res. 2022. PMID: 35340062 Free PMC article. Clinical Trial.
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3).
Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching DWT, Messina OD, Burmester GR, Bartok B, Pechonkina A, Kondo A, Yin Z, Guo Y, Tasset C, Sundy JS, Takeuchi T. Atsumi T, et al. Mod Rheumatol. 2022 Feb 28;32(2):273-283. doi: 10.1093/mr/roab021. Mod Rheumatol. 2022. PMID: 34910203 Clinical Trial.
31 results